Global $2.27 Billion Adalimumab, Infliximab and Etanercept Biosimilars Market to 2030
03 févr. 2021 04h43 HE
|
Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to...
Graft Versus Host Disease (GVHD) Pipeline Review 2020: Therapeutics Development, Therapeutics Assessment and Companies Involved in Therapeutics Development
27 oct. 2020 05h03 HE
|
Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides...
Global Immunosuppressant Drugs Market Report 2019-2020 & 2028: Focus on Corticosteroids, Monoclonal Antibodies, Calcineurin Inhibitors, Mtor Inhibitors
29 sept. 2020 06h14 HE
|
Research and Markets
Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Immunosuppressant Drugs Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global immunosuppressant drugs...
$1.3B Immunosuppressant Drugs Industry 2020-2025 - Breakdown by Drug Class, Application, Distribution Channel, End User and Region
28 août 2020 05h34 HE
|
Research and Markets
Dublin, Aug. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Immunosuppressant Drugs Market by Application, Product and Sales Channel, Geography and the Impact of Covid-19 (2020-2025)" report has been...
Ankylosing Spondylitis Drugs Market To Reach USD 8.82 Billion By 2027 | Reports And Data
11 févr. 2020 16h00 HE
|
Reports and Data
New York, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global ankylosing spondylitis drugs market is forecast to reach USD 8.82 Billion by 2027, according to a new report by Reports and Data. Ankylosing...